Literature DB >> 17158636

Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.

Gary M Tse1, Benjaporn Chaiwun, Kin-Mang Lau, Richard Scolyer, C Soon Lee, Rooshdiya Z Karim, Thomas C Putti, Bonita K Law, Philip C Lui, Puay Hoon Tan.   

Abstract

BACKGROUND AND AIMS: Endothelin-1 expression is increased in infiltrating duct carcinoma and is associated with larger tumour size, higher histological grade and lymphovascular permeation. This has not been evaluated in phyllodes tumours, which are uncommon fibroepithelial lesions with potential for local recurrences or distant metastasis. While the grading of phyllodes tumours depends on a combination of histological parameters, prediction of their behaviour remains difficult.
METHOD: A large series of 461 phyllodes tumours (291 benign, 115 borderline malignant and 55 frankly malignant) were evaluated for endothelin-1 expression in both the epithelial cells and stromal cells by immunohistochemistry; results were correlated with the tumour grade.
RESULTS: For benign phyllodes tumours, the epithelial staining of endothelin was negative, weak, moderate and strong in 6%, 26%, 15% and 53% of cases respectively; results were 4%, 18%, 19% and 59% respectively for borderline and 6%, 18%, 6% and 70% respectively for frankly malignant tumours. For the stromal staining, the negative, weak, moderate and strong staining was 32%, 19%, 18% and 31% respectively for benign phyllodes, 24%, 13%, 10% and 53% respectively for borderline and 8%, 16%, 17% and 59% respectively for frankly malignant tumours. There was correlation between epithelial and stromal staining, and the stromal staining correlated with histological features of stromal cellularity, stromal cell nuclear pleomorphism, margin status and stromal overgrowth.
CONCLUSION: These observations suggest a close relationship between the epithelial and stromal elements in phyllodes tumours; endothelin may play a significant role in the malignant progression of phyllodes tumours.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158636      PMCID: PMC1972415          DOI: 10.1136/jcp.2006.044354

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  40 in total

1.  The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes.

Authors:  R E Hawkins; J B Schofield; C Fisher; E Wiltshaw; J A McKinna
Journal:  Cancer       Date:  1992-01-01       Impact factor: 6.860

2.  A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts.

Authors:  N Takuwa; Y Takuwa; M Yanagisawa; K Yamashita; T Masaki
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin.

Authors:  Y Itoh; M Yanagisawa; S Ohkubo; C Kimura; T Kosaka; A Inoue; N Ishida; Y Mitsui; H Onda; M Fujino
Journal:  FEBS Lett       Date:  1988-04-25       Impact factor: 4.124

5.  Treatment options and recurrence potential for cystosarcoma phyllodes.

Authors:  M L Palmer; D C De Risi; A Pelikan; J Patel; T Nemoto; D Rosner; T L Dao
Journal:  Surg Gynecol Obstet       Date:  1990-03

6.  Phyllodes tumor of the breast: a clinicopathologic study of 34 cases.

Authors:  K Kario; S Maeda; Y Mizuno; Y Makino; H Tankawa; S Kitazawa
Journal:  J Surg Oncol       Date:  1990-09       Impact factor: 3.454

7.  Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells.

Authors:  Francesca Spinella; Laura Rosanò; Valeriana Di Castro; Pier Giorgio Natali; Anna Bagnato
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

Review 8.  Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases.

Authors:  C J Moffat; S E Pinder; A R Dixon; C W Elston; R W Blamey; I O Ellis
Journal:  Histopathology       Date:  1995-09       Impact factor: 5.087

9.  The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases.

Authors:  M Reinfuss; J Mituś; K Duda; A Stelmach; J Ryś; K Smolak
Journal:  Cancer       Date:  1996-03-01       Impact factor: 6.860

10.  Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.

Authors:  H Ehrenreich; R W Anderson; C H Fox; P Rieckmann; G S Hoffman; W D Travis; J E Coligan; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  2 in total

1.  Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions.

Authors:  Eman Taha Ali; Mai Abdulrahman Mohammed Masri; Emmanuel Edwar Siddig; Ayman Ahmed; Mohamed S Muneer; Nouh Saad Mohamed; Ali Mahmoud Mohammed Edris
Journal:  BMC Res Notes       Date:  2020-06-23

2.  Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center.

Authors:  Jing Wei; Yu-Ting Tan; Yu-Cen Cai; Zhong-Yu Yuan; Dong Yang; Shu-Sen Wang; Rou-Jun Peng; Xiao-Yu Teng; Dong-Geng Liu; Yan-Xia Shi
Journal:  Chin J Cancer       Date:  2014-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.